| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.7 | 0.0008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |